Company profile: Trillium Health Care Products
1.1 - Company Overview
Company description
- Provider of contract manufacturing, formulation, packaging, and project management for OTC and natural health products. Capabilities span solid dose (tablets, capsules, granules, powders), liquid dose (solutions, suspensions, lotions, syrups), and semi-solid dose (creams, ointments, wax-based suppositories), plus tube/jar/suppository filling, specialized labeling and custom display packaging, and concept-to-commercialization support.
Products and services
- Liquid Dose Manufacturing: Produces and packages solutions, suspensions, lotions, and syrups for OTC products, delivering industrial-grade liquid dose processing and complete packaging across specified formulation types
- Product Formulation: Develops new natural health and OTC drug products—cough cold remedies, therapeutic skin and hair care, gastrointestinal treatments, sleep aids, oral care—via custom-engineered formulation and focused development programs
- Solid Dose Manufacturing: Fabricates and packages tablets (solid, chewable, rapid dissolving), capsules, granules, and powders for OTC medications, providing industrial-grade solid-dose production and multi-format oral delivery options
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trillium Health Care Products
Medivir
HQ: Sweden
Website
- Description: Provider of research-based pharmaceuticals focused on oncology and infectious diseases, leveraging protease inhibitor design and nucleotide/nucleoside science to address unmet medical needs. Portfolio includes MIV-818 for liver cancer, remetinostat for early-stage MF-CTCL, and VBX-1000 with positive proof-of-concept results. Also offers quarterly report conference calls and investor presentations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medivir company profile →
Aragen Bioscience
HQ: United States
Website
- Description: Provider of preclinical contract research and development services specializing in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, mammalian protein expression, primary and immortalized cell-based assays, in vivo models of human disease, custom immunological services, preclinical efficacy studies, and vivarium-based rodent studies including BSL-2 suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aragen Bioscience company profile →
Kentucky Clinical Trials Laboratory
HQ: United States
Website
- Description: Provider of pharmaceutical and diagnostic clinical trials, specimen collection, and medical studies to support research, development, and regulatory transition of novel products in medicine for business organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kentucky Clinical Trials Laboratory company profile →
J+D Forecasting
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical forecasting software, pharma training, and consultancy services as a business consulting firm.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full J+D Forecasting company profile →
Accupac
HQ: United States
Website
- Description: Provider of integrated formulation, manufacturing, packaging, and procurement services for pharmaceutical and personal care products on an outsourced basis, offering project management from concept to commercialization, in-house analytical and microbiology testing, new product development via Cobalt Labs, and liquid/emulsion filling; batch sizes 100–19,000 KGS and 1.9B ounces capacity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accupac company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trillium Health Care Products
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trillium Health Care Products
2.2 - Growth funds investing in similar companies to Trillium Health Care Products
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trillium Health Care Products
4.2 - Public trading comparable groups for Trillium Health Care Products
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →